Science Business Announcements

National Comprehensive Cancer Network's patient information team provides a patient and caregiver version of recently updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.

Journal of Cell Biology, Journal of Experimental Medicine, and Journal of General Physiology announce an editorial policy allowing swift and confidential updates to author names at any time and for any reason including changes to gender identity, marriage, divorce, religion, or other personal circumstances.

The funding will support the pre-clinical advancement of dual IRAK1/4 and panFLT3 inhibitors to target cancer cells that evade the effects of both targeted therapy and chemotherapy drugs via adaptive resistance mechanisms, having co-opted IRAK1/4-mediated immune signaling pathways to survive.

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies. A5386 will study whether N-803 (a clinical-stage biologic also called Anktiva?) can control HIV alone or together with combination broadly neutralizing antibodies (bNAbs) after participants stop their antiretroviral therapy (ART) and they are carefully monitored.

Thousands of babies on ventilators worldwide are affected by a common breathing tube incident that could result in a lifelong disability, brain damage or even death. Researchers from Purdue University spent 30 years developing a solution that can now be offered to all NICUs, thanks to the availability of the device through one of the largest medical technology companies in the world, Medtronic.

The new limits for the Cordillera de Coiba protected area were determined by a consulting team led by Hector Guzman, a marine biologist at the Smithsonian Tropical Research Institute. With this action, Panama reaches the goal of the 30x30 Initiative nine years ahead of schedule, charting the course for other countries to follow.